Best of LinkedIn: Health Tech CW 48/ 49

Health Tech activity over the past two weeks showed a clear shift from experimentation to operational rollout. Providers, OEMs, and regulators pushed on AI adoption, imaging automation, and robotic surgery, while reimbursement and ecosystem moves reduced friction for real world scale. The net effect is a market that is tightening the loop between data, clinical workflow, and payment readiness.

Date

December 8, 2025

Health Tech

Thomas Allgeyer

Methodology: Every two weeks we collect most relevant posts on LinkedIn for selected topics and create an overall summary only based on these posts. If you´re interested in the single posts behind, you can find them here: https://linktr.ee/thomasallgeyer. Have a great read!

Listen to our podcast

If you prefer listening, check out our podcast summarizing the most relevant insights from Health Tech Insights CW 48/ 49:

AI Adoption, Governance, and Strategy Moves

Health systems are shifting from AI tool shopping to unified strategies tied to priority outcomes, data maturity, and organizational change
German survey shows fast AI uptake in care delivery, but persistent gaps in skills, governance, and workflow integration slow value realization
New US policy proposals aim to expand patient access to AI enabled services and improve Medicare reimbursement for validated AI
Physician groups emphasized clinician led AI standards, positioning medical societies as the stewards of safe, accountable deployment
Multiple analyses underscored the need for early stakeholder alignment and practical ethics, noting sustainability and equity remain under addressed in hospital AI programs

‍

Diagnostics, Imaging, and Radiology Acceleration

RSNA 2025 highlighted imaging as the leading runway for scalable AI, with interoperability and workflow automation now as critical as model accuracy
Philips and GE showcased AI assisted radiology stacks automating analysis, cutting reading times, and enhancing clinical insight delivery
MRI innovation centered on helium free systems, higher field capability, and AI reconstruction to elevate image fidelity and throughput in constrained settings
Heart Flow plaque analysis hit a major validation milestone for non-invasive coronary risk assessment, strengthening cardiology decision support
Deep learning pancreas MRI reconstruction improved signal and lesion visibility, showing AI’s growing impact on niche, high value protocols
Radiologists were increasingly portrayed as orchestrators of AI enabled diagnostics, transitioning from image readers to data to decision leaders

‍

Robotics, Surgery, and Interventional Tech

Robotic assisted surgery advanced with Medtronic Hugo’s urology clearance, signaling broader procedure expansion ahead
CMR Surgical’s Versius was positioned as modular, scalable, and globally deployable, lowering barriers for minimally invasive care beyond top centers
Emerging non-surgical robotics such as magnetically guided kidney stone treatment pointed to a new class of safe, targeted interventional platforms
Surgical and endoscopic communities pushed for closer collaboration, supporting converging workflows for hybrid procedures
Device innovation remained active, with new evidence on surgical staplers and extensive hands-on demonstrations across major surgery congresses

‍

Digital Care Delivery, Virtual Health, and Reimbursed DTx

Virtual care continued consolidating into employer and system partnerships, spotlighted by Teladoc’s collaboration with Tulane to strengthen employee care journeys
Switzerland’s reimbursement approval for digital health apps marked another step toward routine DTx access and faster European scale pathways
Movement of acute care into the home was framed as execution heavy, requiring clinician trust, remote monitoring infrastructure, and redesigned team models
Behavioral health commentary stressed that technology should enhance human connection, establishing hybrid models as the durable long-term approach
Physitrack’s global expansion illustrated that scaled digital therapeutics now compete on operations and delivery, not only clinical evidence
Regional platforms such as Lumeo RHIS and the Azores program showed progress toward cross organization data exchange essential for platform-based care

‍

Ecosystem, R&D, and Market Momentum

Mayo Clinic and GE HealthCare expanded collaboration on AI enabled personalized radiation therapy, signaling deeper integration of AI into core oncology care
AI driven drug discovery including AlphaFold based pipelines was highlighted as compressing timelines and broadening viable target universes
Calls for genomic newborn screening intensified, linking early detection to long term cost avoidance and improved population health
Stroke AI and imaging assisted decision support programs across France and the US emerged as partnership ready blueprints for validated, scalable deployment
Market signals showed stable momentum across regulatory approvals, financings, and leadership hires, indicating a healthy innovation pipeline
Macro commentary reinforced a shift from sick care to wellness care, expanding the addressable market and raising expectations for continuous, data driven prevention

‍

Subscribe to newsletter

Subscribe to receive the latest blog posts to your inbox every week.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Results that speak

How we solve real problems for real clients

Screen. Map. Reach out

Capture the KHZG Hospital Digitalization Wave

See more Cases

Das sind wir

Wir arbeiten mit Führungskräften, die den Status quo ablehnen. Unsere Teams bringen tiefes Branchenwissen und einen klaren Fokus auf Ergebnisse.

let's talk